{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:52:06Z","timestamp":1773028326349,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vascn.2021.107071","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:37:50Z","timestamp":1619743070000},"page":"107071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Mouse models for actinic keratoses"],"prefix":"10.1016","volume":"110","author":[{"given":"Justin","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron E.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youkyung S.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishadh","family":"Sutaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan M.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vascn.2021.107071_bb0005","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/carcin\/bgq122","article-title":"Topical application of valrubicin has a beneficial effect on developing skin tumors","volume":"31","author":"Andersen","year":"2010","journal-title":"Carcinogenesis"},{"issue":"Suppl. 5","key":"10.1016\/j.vascn.2021.107071_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdv.14375","article-title":"New and current preventive treatment options in actinic keratosis","volume":"31","author":"Arenberger","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107071_bb0015","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1038\/s41467-020-16475-3","article-title":"Chronic expression of p16INK4a in the epidermis induces Wnt-mediated hyperplasia and promotes tumor initiation","volume":"11","author":"Azazmeh","year":"2020","journal-title":"Nature Communications"},{"issue":"7","key":"10.1016\/j.vascn.2021.107071_bb0020","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/02656736.2017.1408858","article-title":"Application of dynamic thermal imaging in a photocarcinogenesis mouse model","volume":"34","author":"Baek","year":"2018","journal-title":"International Journal of Hyperthermia: The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group"},{"issue":"12","key":"10.1016\/j.vascn.2021.107071_bb0025","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.jid.2018.05.028","article-title":"A hexokinase 2 modulator for field-directed treatment of experimental actinic Keratoses","volume":"138","author":"Behar","year":"2018","journal-title":"The Journal of Investigative Dermatology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107071_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdermsci.2008.08.012","article-title":"The hairless mouse in skin research","volume":"53","author":"Benavides","year":"2009","journal-title":"Journal of Dermatological Science"},{"issue":"1 Suppl 1","key":"10.1016\/j.vascn.2021.107071_bb0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jaad.2012.09.053","article-title":"Pathobiology of actinic keratosis: Ultraviolet-dependent keratinocyte proliferation","volume":"68","author":"Berman","year":"2013","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1016\/j.vascn.2021.107071_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13555-016-0137-2","article-title":"Ingenol disoxate: A novel 4-Isoxazolecarboxylate Ester of Ingenol with improved properties for treatment of actinic keratosis and other non-melanoma skin cancers","volume":"6","author":"Bertelsen","year":"2016","journal-title":"Dermatology and Therapy"},{"issue":"2","key":"10.1016\/j.vascn.2021.107071_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jphotobiol.2010.09.012","article-title":"Photodynamic therapy using topically applied hypericin: Comparative effect with methyl-aminolevulinic acid on UV induced skin tumours","volume":"102","author":"Boiy","year":"2011","journal-title":"Journal of Photochemistry and Photobiology. B"},{"key":"10.1016\/j.vascn.2021.107071_bb0050","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.25251\/skin.2.supp.76","article-title":"VDA-1102: A novel well-tolerated treatment for actinic keratosis","volume":"2","author":"Brickman","year":"2018","journal-title":"SKIN The Journal of Cutaneous Medicine"},{"issue":"2","key":"10.1016\/j.vascn.2021.107071_bb0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/carcin\/bgs349","article-title":"Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinoma","volume":"34","author":"Burns","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.vascn.2021.107071_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphotobiol.2019.04.007","article-title":"Looking beyond the skin: Cutaneous and systemic oxidative stress in UVB-induced squamous cell carcinoma in hairless mice","volume":"195","author":"Carrara","year":"2019","journal-title":"Journal of Photochemistry and Photobiology. B, Biology"},{"issue":"8","key":"10.1016\/j.vascn.2021.107071_bb0065","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.onc.1210726","article-title":"Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis","volume":"27","author":"Chan","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.vascn.2021.107071_bb0070","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1038\/ncomms12601","article-title":"Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates","volume":"7","author":"Chitsazzadeh","year":"2016","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.vascn.2021.107071_bb0075","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/jid.2011.418","article-title":"Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches","volume":"132","author":"Cozzi","year":"2012","journal-title":"The Journal of Investigative Dermatology"},{"issue":"5","key":"10.1016\/j.vascn.2021.107071_bb0080","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1684\/ejd.2013.2155","article-title":"Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effects","volume":"23","author":"Crain","year":"2013","journal-title":"European Journal of Dermatology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107071_bb0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","article-title":"Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy","volume":"127","author":"Cunningham","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.vascn.2021.107071_bb0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/09546634.2016.1254328","article-title":"Real-world approach to actinic keratosis management: Practical treatment algorithm for office-based dermatology","volume":"28","author":"Dirschka","year":"2017","journal-title":"The Journal of Dermatological Treatment"},{"issue":"11","key":"10.1016\/j.vascn.2021.107071_bb0095","first-page":"B5368","article-title":"Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer","volume":"64","author":"Erlendsson","year":"2017","journal-title":"Danish Medical Journal"},{"issue":"9","key":"10.1016\/j.vascn.2021.107071_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162597","article-title":"Repeated treatments with ingenol mebutate prevents progression of UV-induced photodamage in hairless mice","volume":"11","author":"Erlendsson","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl. 2","key":"10.1016\/j.vascn.2021.107071_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdv.14151","article-title":"From actinic keratosis to squamous cell carcinoma: Pathophysiology revisited","volume":"31","author":"Fernandez Figueras","year":"2017","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1016\/j.vascn.2021.107071_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fmed.2018.00165","article-title":"Pathogenesis of skin carcinomas and a stem cell as focal origin","volume":"5","author":"de Gruijl","year":"2018","journal-title":"Frontiers in Medicine"},{"issue":"3","key":"10.1016\/j.vascn.2021.107071_bb0115","first-page":"979","article-title":"Development of skin tumors in hairless mice after discontinuation of ultraviolet irradiation","volume":"51","author":"de Gruijl","year":"1991","journal-title":"Cancer Research"},{"key":"10.1016\/j.vascn.2021.107071_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000366534","article-title":"Mouse models for actinic keratosis and squamous cell carcinoma","volume":"46","author":"Handoko","year":"2015","journal-title":"Current Problems in Dermatology"},{"key":"10.1016\/j.vascn.2021.107071_bb0125","doi-asserted-by":"crossref","first-page":"33952","DOI":"10.1038\/srep33952","article-title":"Thickness of actinic keratosis does not predict dysplasia severity or P53 expression","volume":"6","author":"Heerfordt","year":"2016","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.vascn.2021.107071_bb0130","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2012.03.048","article-title":"Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling","volume":"149","author":"Hu","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.vascn.2021.107071_bb0135","first-page":"1289","article-title":"Histogenesis and progression in ultraviolet light-induced tumors in hairless mice","volume":"67","author":"Kligman","year":"1981","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.vascn.2021.107071_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111565","article-title":"Citral prevents UVB-induced skin carcinogenesis in hairless mice","volume":"198","author":"Kremer","year":"2019","journal-title":"Journal of Photochemistry and Photobiology. B, Biology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107071_bb0145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bjc.2013.760","article-title":"Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling","volume":"110","author":"Lambert","year":"2014","journal-title":"British Journal of Cancer"},{"issue":"10","key":"10.1016\/j.vascn.2021.107071_bb0150","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jid.2017.04.039","article-title":"HPV8 field cancerization in a transgenic mouse model is due to Lrig1+ keratinocyte stem cell expansion","volume":"137","author":"Lanfredini","year":"2017","journal-title":"The Journal of Investigative Dermatology"},{"issue":"7","key":"10.1016\/j.vascn.2021.107071_bb0155","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2174\/1871520618666171229190835","article-title":"Astragalin attenuates UVB radiation-induced actinic keratosis formation","volume":"18","author":"Li","year":"2018","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"issue":"4","key":"10.1016\/j.vascn.2021.107071_bb0160","doi-asserted-by":"crossref","DOI":"10.5070\/D3214026285","article-title":"Topical AC-11 abates actinic keratoses and early squamous cell cancers in hairless mice exposed to ultraviolet a (UVA) radiation","volume":"21","author":"Mentor","year":"2015","journal-title":"Dermatology Online Journal"},{"issue":"1","key":"10.1016\/j.vascn.2021.107071_bb0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/jid.2013.278","article-title":"RhoB promotes cancer initiation by protecting keratinocytes from UVB-induced apoptosis but limits tumor aggressiveness","volume":"134","author":"Meyer","year":"2014","journal-title":"The Journal of Investigative Dermatology"},{"issue":"5","key":"10.1016\/j.vascn.2021.107071_bb0170","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3892\/or.2016.4683","article-title":"Chemically induced skin carcinogenesis: Updates in experimental models (review)","volume":"35","author":"Neagu","year":"2016","journal-title":"Oncology Reports"},{"issue":"5","key":"10.1016\/j.vascn.2021.107071_bb0175","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1097-2765(00)80350-0","article-title":"Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion","volume":"3","author":"Pelengaris","year":"1999","journal-title":"Molecular Cell"},{"issue":"6","key":"10.1016\/j.vascn.2021.107071_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179991","article-title":"Actinic keratosis modelling in mice: A translational study","volume":"12","author":"Pillon","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vascn.2021.107071_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071887","article-title":"A role for NF-\u03baB activity in skin hyperplasia and the development of keratoacanthomata in mice","volume":"8","author":"Poligone","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vascn.2021.107071_bb0190","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","article-title":"From keratinocyte to cancer: The pathogenesis and modeling of cutaneous squamous cell carcinoma","volume":"122","author":"Ratushny","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"issue":"1797","key":"10.1016\/j.vascn.2021.107071_bb0195","first-page":"25","article-title":"Managing actinic keratosis in primary care","volume":"260","author":"Salmon","year":"2016","journal-title":"The Practitioner"},{"issue":"5","key":"10.1016\/j.vascn.2021.107071_bb0200","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00204-012-0998-9","article-title":"Non-melanoma skin cancer in mouse and man","volume":"87","author":"Schwarz","year":"2013","journal-title":"Archives of Toxicology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107071_bb0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/carcin\/bgn278","article-title":"A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model","volume":"30","author":"Serrels","year":"2009","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.vascn.2021.107071_bb0210","first-page":"187","article-title":"Anti-tumor activity of rosmarinic acid in 7,12-dimethylbenz(a)anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice","volume":"50","author":"Sharmila","year":"2012","journal-title":"Indian Journal of Experimental Biology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107071_bb0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0304-3835(88)90055-9","article-title":"Sensitivity of HRA\/Skh hairless mice to initiation\/promotion of skin tumors by chemical treatment","volume":"41","author":"Steinel","year":"1988","journal-title":"Cancer Letters"},{"issue":"8","key":"10.1016\/j.vascn.2021.107071_bb0220","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1346-8138.12572","article-title":"Photodynamic therapy using a novel irradiation source, LED lamp, is similarly effective to photodynamic therapy using diode laser or metal-halide lamp on DMBA- and TPA-induced mouse skin papillomas","volume":"41","author":"Takahashi","year":"2014","journal-title":"The Journal of Dermatology"},{"key":"10.1016\/j.vascn.2021.107071_bb0225","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3389\/fmicb.2017.02197","article-title":"Induction of tyrosine phosphorylation of UV-activated EGFR by the beta-human papillomavirus type 8 E6 leads to papillomatosis","volume":"8","author":"Taute","year":"2017","journal-title":"Frontiers in Microbiology"},{"issue":"7","key":"10.1016\/j.vascn.2021.107071_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002125","article-title":"E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice","volume":"7","author":"Viarisio","year":"2011","journal-title":"PLoS Pathogens"},{"issue":"1","key":"10.1016\/j.vascn.2021.107071_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.0022-202X.2005.23733.x","article-title":"Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers","volume":"125","author":"Weissenborn","year":"2005","journal-title":"The Journal of Investigative Dermatology"},{"issue":"10","key":"10.1016\/j.vascn.2021.107071_bb0240","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mc.21901","article-title":"Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1\/Th17 cells","volume":"52","author":"Yokogawa","year":"2013","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.vascn.2021.107071_bb0245","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ebiom.2016.06.011","article-title":"A mouse model of hyperproliferative human epithelium validated by keratin profiling shows an aberrant cytoskeletal response to injury","volume":"9","author":"Zhussupbekova","year":"2016","journal-title":"EBioMedicine"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:04:18Z","timestamp":1761005058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871921001234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":49,"alternative-id":["S1056871921001234"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107071","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mouse models for actinic keratoses","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107071"}}